DE69124215T2 - Primaten-lentivirus impfstoffe - Google Patents

Primaten-lentivirus impfstoffe

Info

Publication number
DE69124215T2
DE69124215T2 DE69124215T DE69124215T DE69124215T2 DE 69124215 T2 DE69124215 T2 DE 69124215T2 DE 69124215 T DE69124215 T DE 69124215T DE 69124215 T DE69124215 T DE 69124215T DE 69124215 T2 DE69124215 T2 DE 69124215T2
Authority
DE
Germany
Prior art keywords
disclosed
vaccine
null mutation
primate lentivirus
revertible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69124215T
Other languages
English (en)
Other versions
DE69124215D1 (de
Inventor
Ronald Desrosiers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of DE69124215D1 publication Critical patent/DE69124215D1/de
Application granted granted Critical
Publication of DE69124215T2 publication Critical patent/DE69124215T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69124215T 1990-07-12 1991-07-10 Primaten-lentivirus impfstoffe Expired - Fee Related DE69124215T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55194590A 1990-07-12 1990-07-12
PCT/US1991/004884 WO1992000987A1 (en) 1990-07-12 1991-07-10 Primate lentivirus vaccines

Publications (2)

Publication Number Publication Date
DE69124215D1 DE69124215D1 (de) 1997-02-27
DE69124215T2 true DE69124215T2 (de) 1997-08-07

Family

ID=24203310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69124215T Expired - Fee Related DE69124215T2 (de) 1990-07-12 1991-07-10 Primaten-lentivirus impfstoffe

Country Status (5)

Country Link
EP (1) EP0491930B1 (de)
JP (1) JPH05501654A (de)
AT (1) ATE147782T1 (de)
DE (1) DE69124215T2 (de)
WO (1) WO1992000987A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017825A1 (en) * 1993-02-05 1994-08-18 The Regents Of The University Of California Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
US6015661A (en) * 1994-02-14 2000-01-18 The Macfarlane Burnet Centre For Medical Research Limited Methods for the detection of non-pathogenic HIV-1 strains containing deletions in the Nef coding region and U3 region of the LTR
EP0754223B8 (de) * 1994-02-14 2007-08-01 The Macfarlane Burnet Centre For Medical Research Limited Nicht pathogene stämme des hiv-1
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
WO1995026361A1 (en) * 1994-03-25 1995-10-05 Biomolecular Research Institute Ltd. Vpr AND Vpx PROTEINS OF HIV
ATE405635T1 (de) * 1994-12-27 2008-09-15 Sateesh N Apte Menschliche hiv impfstoffe und therapeutika beinhaltend hinsichtlich der replikation eingeschränkte hiv-1 nef-deletionsmutanten
EP0873415B1 (de) * 1995-04-14 2008-09-10 University Of Alabama Research Foundation Transfer system basierend auf einem fusionsprotein und seine anwendungen.
US6004799A (en) * 1996-03-05 1999-12-21 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral DNA vaccines
WO1998050070A1 (en) * 1997-05-02 1998-11-12 University Of Kansas Medical Center Live virus vaccines to protect primates from hiv-1 infection and disease
WO1999061049A2 (en) * 1998-05-22 1999-12-02 University Of Massachusetts Medical Center Model for infection by a pathogen using administration of nucleic acids
US6555342B1 (en) 1998-06-03 2003-04-29 Uab Research Foundation Fusion protein delivery system and uses thereof
US7622300B2 (en) 1998-06-03 2009-11-24 Kappes John C Trans-lentiviral vector particles and transduction of eukaryotic cells therewith
CN1173036C (zh) * 1999-04-21 2004-10-27 卫生部艾滋病预防与控制中心 马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列
WO2024048793A1 (ja) * 2022-09-02 2024-03-07 国立研究開発法人医薬基盤・健康・栄養研究所 感染を治療するための弱毒化ウイルス

Also Published As

Publication number Publication date
DE69124215D1 (de) 1997-02-27
EP0491930A1 (de) 1992-07-01
JPH05501654A (ja) 1993-04-02
EP0491930B1 (de) 1997-01-15
EP0491930A4 (en) 1993-12-29
ATE147782T1 (de) 1997-02-15
WO1992000987A1 (en) 1992-01-23

Similar Documents

Publication Publication Date Title
DE69124215T2 (de) Primaten-lentivirus impfstoffe
DE69840383D1 (de) Ctl epitope des epstein-barr virus
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
HUP9802819A2 (hu) Hősokkfehérje-alapú oltóanyagok és immunterápiák
ES2194029T3 (es) Variantes del virus hiv-2.
GEP20032902B (en) Mixture of Recombinant Vaccinia Vectors as Polyenv Vaccines for HIV
SI0887427T1 (sl) Pomnozevanje in detekcija HIV-1 in/ali HIV-2
TR199802329T2 (xx) Enfeksiyon hastal�klar�n�n tedavisinde IL-12 ve IFNalfa kullan�m�.
NZ335612A (en) A composition containing cytotoxic specificT-cell epitopes being either Rev and/or Tat proteins from HIV virus for prevention and treatment of human immunodeficiency virus (HIV) infection
EP0726758A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
EP0687182A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
EP0404625A3 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ITRM920350A1 (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
ATE386049T1 (de) Epstein-barr virus type b ctl epitopen
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
SE9600436D0 (sv) Vaccine against hantavirus
ES2084587T3 (es) Arn virus no revertientes.
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee